THE mode of action of low-molecular weight enzyme inhibitors has been intensively studied. This does not, however, apply to high-molecular weight enzyme inhibitors. So far as we are aware, no work has ...
TORONTO, Jan. 27, 2026 /CNW/ - Eli Lilly Canada, Inc announced today that Jaypirca ® (pirtobrutinib, 100 mg & 50 mg tablets) is now approved and available for use as monotherapy for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results